The coactivity of TNF-α and IFN-γ enhances the expression of immunomodulatory proteins, but the relationship between these cytokines and tumor progression is poorly understood, and research on the relationship between interleukins and disease severity and their role in the pathogenesis of lung cancer is marginally explored. The gene discussed is IFNG; the disease is lung carcinoma.